These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7351151)

  • 1. Density dependence of expiratory flow and bronchodilator response in asthma.
    Ashutosh K; Mead G; Dickey JC; Berman P; Kuppinger M
    Chest; 1980 Jan; 77(1):68-75. PubMed ID: 7351151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled atropine in asthma.
    Snow RM; Miller WC; Blair HT; Rice DL
    Ann Allergy; 1979 May; 42(5):286-9. PubMed ID: 453644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of atropine in the documentation of reversible airways obstruction.
    Brady RE; Easton JG
    Ann Allergy; 1979 Apr; 42(4):211-7. PubMed ID: 373517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of atropine sulfate and isoproterenol hydrochloride in chronic bronchitis.
    Klock LE; Miller TD; Morris AH; Watanabe S; Dickman M
    Am Rev Respir Dis; 1975 Sep; 112(3):371-6. PubMed ID: 1099948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of atropine inhalation in "irreversible" chronic bronchitis.
    Marini JJ; Lakshminarayan S
    Chest; 1980 May; 77(5):591-6. PubMed ID: 7363675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
    Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
    Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term study comparing fenoterol and isoproterenol inhalation in asthmatic patients.
    Brandon ML
    Ann Allergy; 1978 Feb; 40(2):86-93. PubMed ID: 343660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Density dependence of maximal expiratory air flow in asthmatics with exacerbation of their disease.
    Eliasson O; Zuwallack RL
    Am Rev Respir Dis; 1987 Mar; 135(3):573-8. PubMed ID: 3826882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol.
    Ingram RH; Wellman JJ; McFadden ER; Mead J
    J Clin Invest; 1977 Apr; 59(4):696-703. PubMed ID: 845256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of nebulized metaproterenol solution in bronchial asthma.
    Swarts CL; Hyde JS
    Chest; 1976 Nov; 70(5):617-20. PubMed ID: 975978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bronchodilating effects of SCH 1000 with isoproterenol in patients with bronchial asthma.
    Vlagopoulos T; Townley RG; Ghazanshahi S; Bewtra A; Burke K
    Ann Allergy; 1976 Apr; 36(4):223-30. PubMed ID: 131499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sch 1000: a new anticholinergic bronchodilator.
    Gross MJ
    Am Rev Respir Dis; 1975 Dec; 112(6):823-8. PubMed ID: 128306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of airway tone and volume history on maximal expiratory flow in asthma.
    Pichurko BM; Ingram RH
    J Appl Physiol (1985); 1987 Mar; 62(3):1133-40. PubMed ID: 3571070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation.
    Emirgil C; Dwyer K; Baskette P; Sobol BJ
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):215-24. PubMed ID: 805016
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
    Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
    Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Density dependence of maximal expiratory flow in chronic obstructive pulmonary disease.
    Meadows JA; Rodarte JR; Hyatt RE
    Am Rev Respir Dis; 1980 Jan; 121(1):47-53. PubMed ID: 7352713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients.
    Attila M; Muittari A
    Acta Med Scand; 1966 Oct; 180(4):421-7. PubMed ID: 5332472
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the bronchodilator effects of aerosol fenoterol and isoproterenol.
    Steen SN; Smith R; Kuo J; Ziment I; Beall GN
    Chest; 1977 Dec; 72(6):724-30. PubMed ID: 336305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to isoproterenol in a general population sample.
    Lorber DB; Kaltenborn W; Burrows B
    Am Rev Respir Dis; 1978 Nov; 118(5):855-61. PubMed ID: 736356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of aerosolized atropine, isoproterenol, atropine plus isoproterenol, disodium cromoglycate and placebo in the prevention of exercise-induced asthma.
    Tashkin DP; Katz RM; Kerschnar H; Rachelefsky GS; Siegel SC
    Ann Allergy; 1977 Nov; 39(5):311-8. PubMed ID: 411398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.